Pekin Hardy Strauss, Inc. - UROVANT SCIENCES LTD ownership

Quarter-by-quarter ownership
Pekin Hardy Strauss, Inc. ownership history of UROVANT SCIENCES LTD
ValueSharesWeighting
Q4 2020$432,000
-89.1%
26,768
-93.7%
0.08%
-90.7%
Q3 2020$3,961,000
+4.0%
424,127
+9.6%
0.81%
-3.7%
Q2 2020$3,809,000
+73.1%
387,044
+62.1%
0.84%
+69.9%
Q1 2020$2,201,000238,7280.50%
Other shareholders
UROVANT SCIENCES LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 157,480$1,246,0000.82%
Prosight Management, LP 142,620$1,128,0000.57%
Sio Capital Management, LLC 220,042$1,741,0000.42%
Perceptive Advisors 1,875,426$14,835,0000.34%
Park West Asset Management LLC 432,500$3,421,0000.14%
Eventide Asset Management 401,558$3,176,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$7,910,0000.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 51,100$404,0000.01%
Weiss Multi-Strategy Advisers LLC 25,000$198,0000.01%
MILLENNIUM MANAGEMENT LLC 438,911$3,472,0000.01%
View complete list of UROVANT SCIENCES LTD shareholders